Jean-Jacques Bonnet
Affiliations: | Université de Rouen |
Google:
"Jean-Jacques Bonnet"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Nassira Amejdki-Chab | grad student | 1991 | Université de Rouen |
| Amadou Tidjane Corera | grad student | 2000 | Université de Rouen |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Le Maître E, Dourmap N, Vilpoux C, et al. (2013) Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin. Brain Research. 1520: 51-60 |
| Legros H, Dingeval MG, Janin F, et al. (2004) Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. Neurotoxicology. 25: 365-75 |
| Legros H, Janin F, Dourmap N, et al. (2004) Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones. Journal of Neuroscience Research. 75: 429-35 |
| Bonnet JJ. (2003) Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter. European Journal of Pharmacology. 479: 199-212 |
| Syringas M, Janin F, Giros B, et al. (2001) Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake. British Journal of Pharmacology. 133: 387-94 |
| Tidjane Corera A, Do-Régo JC, Costentin J, et al. (2001) Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. Neuroscience Research. 39: 319-25 |
| Syringas M, Janin F, Mezghanni S, et al. (2000) Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport. Molecular Pharmacology. 58: 1404-11 |
| Corera AT, Costentin J, Bonnet JJ. (2000) Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 213-21 |
| Régo JC, Syringas M, Leblond B, et al. (1999) Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat. British Journal of Pharmacology. 128: 51-60 |
| Do-Régo JC, Hue H, Costentin J, et al. (1999) Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine. Journal of Neurochemistry. 72: 396-404 |